CanariaBio Inc.
↗Seoul, South Korea
CanariaBio Inc. is a clinical-stage biotechnology company focused on the development of personalized immunotherapies for various cancers. The company's core technology platform utilizes mono-specific and multi-specific antibodies to stimulate the immune system to recognize and eliminate cancer cells. Its lead product candidate, Oregovomab, is a murine monoclonal antibody targeting the CA125 antigen, which is overexpressed in most epithelial ovarian cancers.
The company was formed through a complex series of acquisitions involving OncoQuest Pharmaceuticals and the South Korean entity CanariaBio M (formerly Doosung Industrial). While the company has historically focused on late-stage clinical trials, it has recently faced significant regulatory and financial headwinds following disappointing results from its lead Phase 3 clinical program.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$0M-$10M (Pre-revenue)
Founded:1994
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$150M+
Investors:CanariaBio M, Quest PharmaTech, Institutional investors via KOSDAQ
STOCK
Exchange:KOSDAQ
Ticker:017670
Market Cap:$45M (Estimated - highly volatile due to recent trading suspensions)
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (Oregovomab)
Modalities:mAb (Monoclonal Antibody), Immunotherapy
Active Trials:3
Trial Phases:Phase 1: 1 | Phase 2: 1 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:CanariaBio M
Subsidiaries:CanariaBio Inc. (USA/Canada), OncoQuest Pharmaceuticals
Key Partnerships:Quest PharmaTech (Technology licensing), Mabwell (Manufacturing and development collaboration)
COMPETITION
Position:Niche Player (Currently struggling due to clinical setbacks)
Competitors:ImmunoGen (Elahere), AstraZeneca (Lynparza), GSK (Zejula), Mersana Therapeutics
LEADERSHIP
Key Executives:
Ravishankar Srinivasan - President & CEO
Madiyalakan Ragupathy - Chairman / Former CEO
Scientific Founders:Dr. Madiyalakan Ragupathy
Board Members:Na-Han-Ik, Ravishankar Srinivasan
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CanariaBio Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.